ArticleHeliyon2024

Deep learning for predicting fibrotic progression risk in diabetic individuals with metabolic dysfunction-associated steatotic liver disease initially free of hepatic fibrosis.

Ruihong Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.